Bruce Evatt MD


Present Positions: Chief, Hematologic Diseases Branch
Division of AIDS, STD, and TB Laboratory Research

Centers for Disease Control
1600 Clifton Road, N.E.
Mailstop E64
Atlanta, Georgia 30333

Education:1953  1957Wayne High School
Wayne, Oklahoma

1957  1960University of Oklahoma
Norman, Oklahoma

1960  1964University of Oklahoma School of Medicine
Oklahoma City, Oklahoma  M.D.

Appointments:1964  1965Intern, Osler Medical Service
The Johns Hopkins Hospital

1965  1966Assistant Resident, Osler Medical Service
The Johns Hopkins Hospital

1966  1968Fellow in Hematology, The Johns Hopkins Hospital

1968  1970Epidemic Intelligence Officer, NCDC, United States Public Health Service, Atlanta, Georgia

1968  1970 Clinical Instructor in Medicine
Emory University School of Medicine

1970  1971Senior Resident, Osler Medical Service
The Johns Hopkins Hospital

1971  1972Fellow in Hematology
The Johns Hopkins Hospital

1972  1973Chief Resident in Medicine
The Johns Hopkins Hospital

1972  1973Instructor in Medicine
The Johns Hopkins Hospital

1973  1976Assistant Professor of Medicine
The Johns Hopkins University School of Medicine

1973  1976Assistant Physician
The Johns Hopkins Hospital

1973  1976Investigator of Howard Hughes Medical Center

1976  1978Chief, Thrombosis and Hemostasis Branch
Hematology Division
Center for Disease Control
Atlanta, Georgia

1976  1991Associate Professor
Emory University School of Medicine
Atlanta, Georgia

1978  1982Director, Hematology Division
Centers for Disease Control
Atlanta, Georgia

1982  1991Director, Division of Immunologic, Oncologic, and Hematologic Diseases
Center for Infectious Diseases
Centers for Disease Control
Atlanta, Georgia

1991 - PresentClinical Professor
Emory University School of Medicine
Atlanta, Georgia

1991 - PresentAssistant Director for Hemophilia Activities, Division of HIV/AIDS
National Center for Infectious Diseases
Centers for Disease Control
Atlanta, Georgia

1991 - PresentChief, Hematologic Diseases Branch
Division of HIV/AIDS
National Center for Infectious Diseases
Centers for Disease Control
Atlanta, Georgia

Medical License:Oklahoma, June 17, 1964
Maryland, August 19, 1966
Georgia, October 14, 1969

Certification:1973, American Board of Internal Medicine
1974, American Board of Hematology
1972, Board Eligible, Oncology

Consultant Appointments:
Consultant in Hematology, Fort Howard Veterans Administration Hospital
World Health Organization

Editorial Boards
Ad Hoc Reviewer:American Journal of Medicine
American Journal of Public Health
Annals of Internal Medicine
BLOOD  The Journal of the American Society of Hematology
Journal of Acquired Immune Deficiency Syndromes
Journal of the American Medical Association
Journal of Laboratory Clinical Medicine
New England Journal of Medicine

Committees:1976CDC Liaison to International Society for Thrombosis and Hemostasis

1977National Committee for Clinical Laboratory Standards Subcommittee on Coagulation
19771984Medical Director and Member, Board of Directors, Hemophilia of Georgia
19791983American Society of Hematology, Subcommittee on Clinical Laboratory Standards
19791984CDC Liaison to International Committee for Standardization in Haematology
19831987American Society of Hematology, Subcommittee on Hemostasis
19841990Public Health Service AIDS Task Force on Blood and Blood Products
19851990National Hemophilia Foundation AIDS Task Force Committee
1987FDA Blood and Blood Products Advisory Committee
19881991National Blood Resource Education Program Coordinating Committee, PHS, NIH, NHLBI (National Heart, Lung, and Blood Institute)
19881995Chairman, AIDS Education Committee World Federation of Hemophilia
19881994Medical Secretary, World Federation of Hemophilia
1994-PresentMember Executive Committee, World Federation Hemophilia
2000-PresentVice-President Developing World. World Federation of Hemophilia

Societies:1958  Sigma Pi Sigma (Honorary Physics Society)
1965  AOA (Honorary Medicine)
1972  American Federation for Clinical Research
1977  American Society of Hematology
1986  Sigma Xi

Awards:1973  The Francis S. Schwentker Award for Research,
Johns Hopkins University
1983  PHS Award, Hemophilia Association of New Jersey
1984  Stewart Wolfe Lectureship, University of Oklahoma
1984  PHS Commendation Medal
1985  Dr. Murray Thelin Award for Distinguished Research
1985  Dr. L. Michael Kuhn Award for Outstanding Governmental Leadership
1987  PHS Meritorious Service Medal

  1.Smith EW, Evatt BL.  Electrophoresis of hemoglobins following the application of whole blood samples to acrylamide gel.  J Lab Clin Med 69:10181024, 1967.

  2.Evatt BL, Mondzac AM, Gaintner JR.  Chronic monocytic leukemia:  a clinical appraisal. Ann Int Med (Abst) 66:1041, 1967.

  3.Evatt BL, Levin J.  Measurement of thrombopoiesis in rabbits using 75selenomethionine.  J Clin Invest 48:16151626, 1969.

  4.McIntyre PA, Evatt BL, Hodkinson BA, Scheffel U.  Selenium75 selenomethionine as a label for erythrocytes, leukocytes, and platelets in man.  J Lab Clin Med 75:472480, 1970.

  5.Kyle RA, Herber L, Evatt BL, Heath CW.  Multiple myeloma.  JAMA 213:13391341, 1970.

  6.Levin J, Shreiner DP, Evatt BL.  Studies of thrombopoiesis using selenomethionine75 SE.  In:  Platelet Kinetics.  Paulus JM, ed.  NorthHolland Publishing Company, pp. 126130, 1971.

  7.Levin J, Shreiner DP, Evatt BL.  Assay of thrombopoietin in rabbits using 75 SEselenomethionine.  In:  Platelet Kinetics.  Paulus JM, ed.  NorthHolland Publishing Company, pp. 152157, 1971.

  8.Evatt BL, Dowdle W, Johnson M, Heath CW.  Epidemic mycoplasma pneumonia.  New Engl J Med 285:374378, 1971.

  9.Heath CW, Evatt BL.  Observations concerning the timespace distributions of childhood acute leukemia in DeKalb County, Georgia.  In:  Proceedings of the 6th Annual Conference on Trace Substances in Environmental Health.  Hemphill DD, ed.  University of Missouri, pp. 2327, 1973.

 10.Evatt BL, Chase, GA, Heath CW.  Timespace clustering among cases of acute leukemia in two Georgia counties.  Blood 41:265272, 1973.

 11.Evatt BL, Shreiner DP, Levin J.  Thrombpoietic activity of fractions of rabbit plasma:  studies in rabbits and mice.  J Lab Clin Med 83:364371, 1974.


12.Levin J, Evatt BL, Shreiner DP.  Measurement of plasma thrombopoiesis stimulating activity using selenomethionine  75 SE:  studies in rabbits and mice.  In:  Platelets:  Production, Function, Tranfusion, and Storage.  Baldini MG, Ebbe S, eds.  Grune and Stratton, pp. 6372, 1974.

 13.Evatt BL, Spivak JL, Levin J.  Relationships between thrombopoiesis and erythropoiesis: with studies of the effects of preparation of thrombopoietin and erythropoietin.  Blood 48:547558, 1976.

 14.Scheffel U, McIntyre PA, Evatt BL, Dvornicky JA, Natarajan TK, Bolling D, Murphy EA.  Evaluation of indiumIII as a new high photon yield gammaemitting "physiological" platelet label.  John Hopkins Med J 140:285293, 1977.

 15.Alving BM, Bell WR, Evatt BL.  Fibrinogen synthesis in rabbits:  effects of altered levels of circulating fibrinogen.  Am J Physiol 232(5):H478H484, 1977.

 16.Alving BA, Evatt BL, Bell WR.  Stimulation of fibrinogen synthesis by thrombin in rabbits with ancrodinduced afibrinogemia.  Am J Physiol 233(5):H562H567, 1977.

 17.Evatt BL.  Computerized calculation of platelet counts obtained with particle counters.  Johns Hopkins Med J 141:163166, 1977.

 18.Evatt BL, Alving BA, Bell WR, Levin J.  Platelet and fibrinogen production:  relative sensitivities to endotoxin.  Thromb Haemost (Abst) 38:30, 1977.

 19.Alving BM, Shulman NR, Bell WR, Evatt BL, Tuck KM.  In vitro studies of heparinassociated thrombocytopenia.  Thromb Res 11:827834, 1977.

 20.Evatt BL.  Monitoring of anticoagulant therapy the prothrombin time.  Center for Disease Control, p. 52, 1978.

 21.Evatt BL.  Kinetics of isotopically labeled platelets.  In:  CRC Handbook of Hematology. Schmidt RM, ed.  pp. 263272, 1979.

 22.Evatt BL.  Platelet production.  In:  CRC Handbook of Hematology.  Schmidt RM, ed.  pp. 255261, 1979.

 23.Sibley C, Evatt BL.  Improving the sensitivity of the Fletcher factor assay.  Am J Clin Path 71:570573, 1979.

 24.Alving BM, Evatt BL, Levin J, Bell WR, Ramsey RB, Levin FC.  Platelet and fibrinogen production:  relative sensitivities to endotoxin. J Lab Clin Med 93:437448, 1979.

 25.Ramsey R, Evatt BL.  Rapid assay for von Willebrand's factor activity using formalinfixed platelets and microtitration technique.  Am J Clin Path 93:437448, 1979.

 26.Stein SF, Evatt BL.  Antiplatelet medication and cardiovascular disease.  In:  Supplement to the Heart.  Hurst WJ, ed.  McGraw Hill, pp. 291303, 1979.

 27.Evatt BL, Sibley C.  Antithrombin III.  DHEW publication.  p. 49, 1979.

 28.Levin J, Evatt BL.  Humoral control of thrombopoiesis.  Blood Cells 5:105121, 1979.

 29.Evatt BL, Levin J, Algazy KM.  Partial purification of thrombopoietin from the plasma of thrombocytopenic rabbits.  Blood 54:377388, 1979.

 30.Evatt B.  The prothrombin time and the clinical laboratory.  American Society of Clinical Pathologists, Check Sample, Thrombosis and Hemostasis No. TH6, 1979.

 31.Evatt BL.  Platelet function and the clinical laboratory.  DHEW publication CDC 7962.  p. 11, 1979.

 32.Fulenwider JT, Sibley C, Stein SF, Evatt, B, Nordlinger BM, Ivey GL.  The endotoxemia of cirrhosis  an observation not substantiated.  Gastroenterology 78:10011004, 1980.

 33.Ramsey RB, Hamner MB, Alving BM, Finlayson JS, Alving CR, Evatt BL.  Effects of lipid A and liposomes containing lipid A on platelet and fibrinogen production in rabbits. Blood 56:307310, 1980.

 34.Barnhart MI, Kim TH, Evatt BL, Ragab AH, Lue VK, Herman J, Lusher JM.  Essential thrombocythemia in a child:  platelet ultrastructure and function.  Am J Hemat 8:87107, 1980.

 35.Waitzman MB, Cornelius LM, Evatt BL.  Treatment of canine spontaneous diabetes mellitus with aspirin.  Metabolic Pediatric Opthalmology 4:151154, 1980.

 36.Hudson EM, Ramsey RB, Evatt BL.  Subcellular localization of indiumIII in indiumIII labeled platelets.  J Lab Clin Med 97(4):577582, 1981.

 37.Evatt BL, van Assendelft O.  Coagulation, standardization, and the 1980's."  In:   Perspectives in Hemostasis.  Fareed J, Messmore HL, Fenton JW, Brinkhouse KM, eds.  Pergamon Press, pp. 373381, 1981.

 38.Stein SF, Fulenwider JT, Ansley JD, Evatt, BL, Nordlinger B, McLemore P, Schwotzer L, Wideman CS.  Accelerated fibrinogen and platelet destruction after peritoneovenous shunting.  Arch Intern Med 141:11491151, 1981.

 39.Fulenwider JT, Stein SF, Wideman CS, Evatt BL.  Reply to letter to editor:  Endotoxemia and cirrhosis and endotoxemia in liver disease.  Gastroenterology 80:418419, 1981.

 40.Fulenwider JT, Stein SF, Wideman CS, Evatt BL.  Reply to letter to editor:  Endotoxemia in cirrhosis.  Gastroenteology 80:1613, 1981.

41.Fulenwider JT, Stein SF, Wideman CS, Evatt BL.  Reply to letter to editor:  Endotoxin and cirrhosis.  Gastroenterology 81:636637, 1981.

 42.Evatt BL.  Oral Anticoagulants.  In:  Interpretations in therapeutic drug monitoring.  Baer DM, Dito WR, eds.  ASCP, pp. 7488, 1981.

 43.Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C.  Deficiency of protein C in congenital thrombotic disease.  J Clin Invest 68:13701373, 1981.

 44.Evatt BL, Brogan D, Triplett D, Koepke J, Waters G.  Effect of thromboplastin and instrumentation on the prothrombin time test.  Clin Lab Haematol 3(4):331342, 1981.

 45.Evatt BL, Kellar KL.  The evolution of techniques for the study of megakaryocyte growth factors.  In:  Megakaryoctye Biology and Precursors:  In Vitro Cloning and Cellular Properties.  Evatt BL, Levine RF, Williams NT, eds.  Elsevier/NorthHolland, pp. 1519, 1981.

 46.Kellar KL, Evatt BL, McGrath CR, Ramsey RB.  Stimulation of DNA synthesis in megakaryocytes by thrombopoietin in vitro.  In:  Megakaryoctye Biology and Precursors: In Vitro Cloning and Cellular Properties.  Evatt BL, Levine RF, Williams NT, eds.  Elsevier/NorthHolland, pp. 2137, 1981.

 47.Evatt BL.  Monitoring of oral anticoagulant therapy.  In:  Laboratory Evaluation of Coagulation.  Triplett DA, ed.  American Society of Clinical Pathologists Press, pp. 245269, 1982.

 48.Evatt BL, Brogan D, Triplett D, Koepke J, Waters G.  Influences of thromboplastin and instrumentation upon prothrombin time tests:  implications for standardization.  In:  Standardization of Coagulation Assays:  An Overview.  Triplett DA, ed.  CAP Conference/Aspen 1980, pp. 3949, 1982.

 49.Gralnick HR, Evatt BL, Huseby RM, Triplett DA.  Procedural standards for the prothrombin time.  In:  Standardization of Coagulation Assays:  An Overview.  Triplett DA, ed.  CAP Conference/Aspen 1980, pp. 5155, 1982.


50.Rose M, Wideman CS, Evatt BL, Haff E.  A comparison of antithrombin III procedures.  Clin Lab Haemat 5:185195, 1983.

 51.Evatt BL, Francis DP, McLane MF, Lee TH, Cabradilla C, Stein SF, Lawrence DN, McDougal JS, Spira TJ, Mullens JI, Essex M.  Antibodies to human T cell leukaemia virusassociated membrane antigens in haemophiliacs:  evidence for infection before 1980.  Lancet ii:698700, 1983.

 52.Essex M, McLane MF, Lee TH, Tachibana N, Mullins JI, Kreiss J, Kasper CK, Poon MC, Landay A, Stein SF, Francis DP, Cabradilla C, Lawrence DN, Evatt BL.  Antibodies to human T cell leukemia virus membrane antigens (HTLVMA) in hemophiliacs.  Science 221:10611064, 1983.

 53.Curran JW, Evatt BL, Lawrence DN.  Acquired immune deficiency syndrome:  the past as prologue.  Ann Intern Med 98:401403, 1983.

 54.Waitzman MB, Kaplan H, Cornelius L, Evatt B, Hunt B.  Aspirin and prostacyclin treatment of diabetic dogs.  Metabolic, Pediatric, Systemic Ophthalmology 7:153158, 1983.

 55.Evatt BL, Ramsey RB, Lawrence DN, Zyla LD, Curran JW.  The acquired immunodeficiency syndrome in patients with hemophilia.  Ann Intern Med 100:499504, 1984.

 56.Ramsey RB, Palmer EL, McDougal JS, Kalyanaraman VS, Jackson DW, Chorba TL, Holman RC, Evatt BL.  Antibody to lymphadenopathyassociated virus in hemophiliacs with and without AIDS.  Lancet ii:397398, 1984.

 57.Palmer EL, Ramsey RB, Feornio PF, Harrison AK, Cabradilla C, Francis DP, Poon MC, Evatt BL.  Human Tcell leukemia virus in lymphocytes of two hemophiliacs with the acquired immunodeficiency syndrome.  Ann Intern Med 101:293297, 1984.

 58.Evatt BL, Chorba TL.  Acquired immunodeficiency syndrome (AIDS) in hemophilia.  In: Clinics in Laboratory Medicine.  Triplett DA, ed.  W.B. Saunders Company 4:33344, 1984.

 59.Triplett DA, Evatt BL, van den Besselaar AMHP.  Proficiency testing and standardization of prothrombin time  potential use of thromboplastin calibration in the United States.  In: Thromboplastin Calibration and Oral Anticoagulant Control.  van den Besselaar AMHP, Gralnick HR, Lewis SM.  Martinus Nijhoff Publishers pp. 209221, 1984.


60.Evatt BL.  Update on AIDS.  In:  Hematology Beyond the Microscope (Proceedings of the 4th Technicon International Hematology Colloquim).  Simson E, ed.  Technicon Instruments Corporation, pp. 18391, 1984.

 61.Jason J, Evatt B, Chorba T, Ramsey R.  Acquired immunodeficiency syndrome (AIDS) in hemophiliacs.  Scand J Hematol 33(suppl 40):34956, 1984.

 62.Griffin JH, Bezeaud A, Evatt B, Mosher D.  Studies of protein C in thromboembolic disease.  La Ricerca Clin Lab 14:469473, 1984.

 63.Evatt BL, Jason JM.  Perspective comprehension of AIDS.  Proc 4th Int Symp, pp. 97102, 1984.

 64.Evatt BL, Chorba TL, McGrady GA, Jason JM.  AIDS in hemophilia.  Proc 4th Int Symp, pp. 114, 1984.

 65.Van Den Beesselaar AM, Evatt BL, Brogan DR, Triplett DA.  Proficiency testing and standardization of prothrombin time:  effect of thromboplastin, instrumentation, and plasma.  Amer Journ Clin Path. 82(6):688-99, 1984.

 66.Tsakok FH, Koh S, Chua SE, Ratnam SS, Tyler CW, Layde P, Evatt BL.  Effects of norethisterone on coagulation and fibrinolysis in Asian women.  Singapore Med Journ. 25(6):442-8, 1984.

 67.Evatt BL, Gomperts ED, McDougal JS, Ramsey RB.  Coincidental appearance of LAV/HTLVIII antibodies in hemophiliacs and the onset of the AIDS epidemic.  N Engl J Med 312:483486, 1985.

 68.Lederman MM, Ratnoff OD, Evatt BL, McDougal JS.  Acquisition of antibody to lymphadenopathyassociated virus in patients with classic hemophilia (factor VIII deficiency).  Ann Intern Med 102:753757, 1985.

 69.Chorba TL, Jason JM, Ramsey RB, Lechner K, PabingerFasching I, Kalyanaraman VS, McDougal JS, Cabradilla CD, Tregillus LC, Lawrence DN, Evatt BL.  HTLVI antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS.  Thromb Haemostasis, 1985.

 70.McDougal JS, Martin LS, Cort SP, Mozen M, Heldebrant CM, Evatt BL.  Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virusIII/lymphadenopathyassociated virus, with special reference to antihemophilic factor.  J Clin Invest 76, 1985.

 71.Jason J, Hilgartner M, Holman RC, Dixon G, Spira TJ, Aledort L, Evatt BL.  Immune status of blood product recipients.  JAMA 253:11405, 1985.

 72.Jason J, McDougal JS, Holman RC, Stein SF, Lawrence DN, Nicholson JKA, Dixon G, Doxey M, Evatt BL, Hemophilia/AIDS Collaborative Study Group.  Human Tlymphotropic retrovirus type III/lymphadenopathyassociated virus antibody.  Association with hemophiliacs' immune status and blood component usage.  JAMA 253:34093415, 1985.

 73.Jason JM, McDougal JS, Cabradilla C, Kalyanaraman VS, Evatt BL.  Human Tcell leukemia virus (HTLVI) P24 antibody in New York City blood product recipients.  Am J Hematol 20:129137, 1985.

 74.Kalyanaraman VS, Narayanan P, Feorino P, Ramsey RB, Palmer EL, Chorba T, McDougal S, Getchell JP, Holloway B, Harrison AK, Cabradilla CD, Telfer M, Evatt BL. Isolation and characterization of a human T cell leukemia virus type II from a hemophiliaA patient with pancytopenia.  EMBO Journal 4:14551460, 1985.

 75.Johnson RE, Lawrence DN, Evatt BL, Bregman DJ, Zyla LD, Curran JW, Aledort LM, Eyster ME, Brownstein AP, Carman CJ.  Acquired immunodeficiency syndrome among patients attending hemophilia treatment centers and mortality experience of hemophiliacs in the United States.  Am J Epidemiol 121:797810, 1985.

 76.Petricciani JC, McDougal JS, Evatt BL.  Case for concluding that heattreated licensed antihaemophilic factor is free from HTLVIII.  Lancet (Letter) II:89089l, 1985.

 77.Stein SF, Evatt BL, McDougal JS, Lawrence DN, Holman RC, Ramsey RB, Spira TJ.  A longitudinal study of patients with hemophilia:  immunologic correlates of infection with HTLVIII/LAV and other viruses.  Blood 66:973979, 1985.

 78.Lawrence DN, Jason JM, Bouhasin JD, McDougal JS, Knutsen AP, Evatt BL, Joist JH.  HTLVIII/LAV antibody status of spouses and household contacts assisting in home infusion of hemophilia patients.  Blood 66:703705, 1985.

 79.Gjerset GF, McGrady G, Counts RB, Martin PJ, Jason J, Kennedy S, Evatt B, Hansen JA. Lymphadenopathyassociated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrate.  Blood 66:718720, 1985.

 80.McDougal JS, Martin LS, Cort SP, Mozen M, Heldebrant CM, Evatt BL.  Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virusIII/lymphadenopathyassociated virus, with special reference to antihemophilic factor.  J Clin Invest 76:875877, 1985.

 81.McDougal JS, Jaffe HW, Cabridilla CD, Sarngadharan MG, Nicholson JKA, Kalyanaraman VS, Schable CA, Kilbourne B, Evatt BL, Gallo RC, Curran JW.  Screening tests for blood donors presumed to have transmitted the acquired immunodeficiency syndrome.  Blood 65:772775, 1985.

 82.Gomperts ED, Feorino P, Evatt BL, Warfield D, Miller R, McDougal JS.  LAV/HTLVIII presence in peripheral blood lymphocytes of seropositive young hemophiliacs.  Blood 65:15491552, 1985.

 83.Lange JV, Mitchel SW, McCormick JB, Walker DH, Evatt BL, McCormick JB, Walker DH, Evatt BL, Ramsey RB.  Kinetic study of platelets and fibrinogen in Lassa virusinfected, monkeys and early pathologic events in Mopeia virusinfected monkeys.  Am J Trop Med Hyg 34:9991007, 1985.

 84.Chorba TL, Brynes R, Kalyanaraman VS, Telfer M, Ramsey R, Mawle A, Palmer EL, Chen ATL, Feorino PM, Evatt BL.  Transformed T lymphocytes infected by a novel isolate of human T cell leukemia virus type II.  Blood 66:13361342, 1985.

 85.Palmer EL, Harrison AK, Ramsey RB, Feorino PM, Francis DP, Evatt BL, Kalyanaraman VS, Martin ML.  Detection of two human T cell leukemia/lymphotropic viruses in cultured lymphocytes of a hemophiliac with acquired immunodeficiency syndrome.  J Infect Dis 151:559563, 1985.

 86.Kellar KL, Rolovic Z, Evatt BL, Sewell ET.  Characteristics of rat megakaryocyte colonies and their progenitors in agar culture.  Exp Hematol 13:10181024, 1985.

 87.Chorba T, Coccia P, Holman RC, Tattersall P, Anderson LJ, Sudman J, Young NS, Kurczynski E, Saarinen UM, Moir R, Lawrence DN, Jason JM, Evatt B.  The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease).  J Infect Dis 154:383393, 1986.

 88.Kellar KL, Rolovic Z, Evatt BL, Sewell ET, Ramsey RB.  Thrombopoietin stimulation of megakaryocytopoiesis in agar culture.  Journ. Progress In Clinica & Biological Research 215:209213, 1986.

 89.Evatt BL, Kellar KL, Ramsey RB.  Thrombopoietin:  Past, present and future.  In:  Megakaryocytes:  Development and Function.  Levine RF, Williams NT, Evatt BL, eds.  Alan R. Liss, Inc., pp. 143155, 1986.

 90.Fenton JW, Wideman CS, Evatt BL.  Thrombin clotting activity measurement and standardization with lyophilized plasma.  Clin Chem 32:320324, 1986.


91.Evatt BL, Yobs AR, Essien JDK.  Interrelationships of proficiency testing programs and standardization in laboratory practice.  In:  Advances in Coagulation Testing:  Interpretation and Application.  Triplett DA, ed.  College of American Pathologists, pp. 273283, 1986.

 92.Jason JM, McDougal JS, Dixon G, Lawrence DN, Kennedy MS, Hilgartner M, Evatt BL.  HTLVIII/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.  JAMA 255:212215, 1986.

 93.Jason JM, Holman RC, Dixon G, Lawrence DN, Bozeman LH, Chorba TL, Tregillus, Evatt BL, The Hemophilia/AIDS Collaborative Study Group.  Effects of exposure to factor concentrates containing donations from identified AIDS patients.  A matched cohort study.  JAMA 256:17581762, 1986.

 94.Levine RF, Williams NT, Evatt BL, eds.  Megakaryocytes:  Development and Function.  Alan R. Liss, Inc., 1986.

 95.Ramsey RB, Evatt BL, McDougal JS, Feorino P, Jackson D.  Antibody to human immunodeficiency virus in factordeficient plasma.  Am J Clin Pathol 87:263266, 1987.

 96.McGrady GA, Jason JM, Evatt BL.  The course of the epidemic of acquired immunodeficiency syndrome in the United States hemophilia population.  Am J Epidemiol 126:2530, 1987.

 97.Chorba TL, Evatt BL.  Hemophiliaassociated acquired immunodeficiency syndrome.  In: Principles of Hematology:  Clinical and Laboratory Practice.  Bick RL, ed.  ThiemeStratton, Inc.  1987.

 98.Chorba TL, Evatt BL.  Transfusionassociated AIDS.  In:  Blood, Blood Products and AIDS.  Madhok R, Forbes CD, Evatt B, eds.  Chapman and Hall Ltd., pp. 1732, 1987.

 99.Hall JD, Willis DW, Evatt BL, Jackson DW.  Using a monoclonal antibody to identify patients with type I and type II von Willebrand's disease.  Thrombosis Haemostasis 57(3):332336, 1987.

100.Hargraves MA, Jason JM, Chorba TL, et al.  Hemophiliac patients' knowledge and educational needs concerning AIDS.  Am J Hematol 126(6):11651172, 1987.

101.Bellinger DA, Nichols TC, Read MS, Reddick RL, and others.   Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor.  Proc Natl Acad Sci USA 84(22):81008104, 1987.

102.McGrady GA, Rettig PJ, Istre GR, Jason JM, and others.  An outbreak of necrotizing enterocolitis.  Association with transfusions of packed red blood cells.  Am J Epidemiol 126(6):11651172, 1987.

103.Evatt BL, Stein SF.  Platelet structure and function.  In:  Platelets.  Smith DM, Summers SH, eds.  American Association of Blood Banks, pp. 214, 1988.

104.Chorba TL, Evatt BL.  Hemophiliaand TransfusionAssociated AIDS.  In:  AIDS Principles, Practices, and Politics.  Corless IB, PittmanLindeman M, eds.  Hemisphere Publishing Corporation, pp. 219234, 1988.

105.Jason JM, StehrGreen J, Holman RC, Evatt BL, the HemophiliaAIDS Collaborative Study Group.  Human immunodeficiency virus infection in hemophilic children.  Pediatrics 82(4):565570, 1988.

106.Kellar KL, Rolovic Z, Evatt BL, Sewell ET, Ramsey RB.  The effects of thrombopoietic activity of rabbit plasma fractions on megakaryocytopoiesis in agar cultures.  Exp Hematol 16(4):262267, 1988.

107.StehrGreen JK, Holman RC, Jason JM, Evatt BL.  Hemophiliaassociated AIDS in the United States, 1981 to September 1987.  Am J Public Health 78(4):439442, 1988.

108.StehrGreen JK, Jason JM, Evatt BL.  Potential effect of revising the CDC surveillance case definition for AIDS.  Lancet 1(8584):520521, 1988.

109.StehrGreen JK, Evatt BL, Lawrence DN.  Acquired immune deficiency syndrome associated with hemophilia in the United States.  In:  Instructional Course Lectures, Volume XXXVIII.  Barr JS, ed., American Academy of Orthopaedic Surgeons, Vol. 38, pp. 357366, 1989.

110.Jason J, Gomperts E, Lawrence DN, Holman RC, Bouhasin JD, Miller R, Evatt BL.  HIV and hemophilic children's growth.  J Acquired Immune Deficiency Syndrome 2(3):277282, 1989.

111.Lawrence DN, Jason JM, Holman RC, Heine P, Evatt BL, the Hemophilia Study Group.  Sex practice correlates of human immunodeficiency virus transmission and acquired immunodeficiency syndrome incidence in heterosexual partners and offspring of U.S. hemophilic men.  Am J Hematology 30(2):6876, 1989.

112.Allon M, Soffer O, Evatt BL, Hixon G, Wideman CS.  Protein S and C antigen levels in proteinuric patients:  dependence on type of glomerular pathology.  Am J Hematol 31(2):96101, 1989.

113.Guarner J, Grossman BJ, Judd RL, Wideman CS, Evatt BL.  Multiple arteriovenous malformations of the small intestine in a patient with protein S deficiency.  Amer J Clin Pathol 92(3):374378, 1989.

114.Horsburgh CR, Jason JM, ... Evatt BL.  Duration of human immunodeficiency virus infection before detection of antibody.  Lancet 637640, Sept. 16 1989.

115.Lairmore MD, Jason JM, Hartley TM, Khabbaz RF, De B, Evatt BL.  Absence of human Tcell lymphotropic virus type I coinfection in human immunodeficiency virusinfected hemophilic men.  Blood 74(7):25962599, 1989.

116.Jason JM, Ou CY, Moore JL, Lawrence DN, Schochetman G, Evatt BL, and the HemophiliaAIDS Collaborative Study Group.  Prevalence of human immunodeficiency virus type 1 DNA in hemophilic men and their sex partners.  J Infect Dis 160(5):789794, 1989.

117StehrGreen JK, Jason JM, Evatt BL and the hemophilia associated AIDS study group.  Geographic variability of hemophiliaassociated AIDS in the United States:  effect of population characteristics.  Am J Hematol 32(3):178-183, 1989.

118.Hooper WC, Pruckler J, Jackson D, Evatt BL.  Transforming growth factor-beta induces hemoglobin synthesis in a human erythroleukemia cell line.  Biochem Biophys Res Commun 165(1):145-150, 1989.

119.Kellar KL, Bridges NB, Monroe MC, Bell BA, Callaway CS, Evatt BL.  Maintenance of normal platelet mass in anemic Belgrade rats and their response to iron.  Exp Hematol 18(9):979-984, 1990.

120.Horsburgh CR, Ou CY, Jason J, Holmberg SD, ... Evatt BL.  Concordance of polymerase chain reaction with human immunodeficiency virus antibody detection.  J Infect Dis 162(2):542-545, 1990.

121.Holman RC, Gomperts ED, Jason JM, Abildgaard CF, ... Evatt BL.  Age and human immunodeficiency virus infection in persons with hemophilia in California.  Am J Public Health 80(8):967-969, 1990.

122.Jason JM, Holman RC, Evatt BL, and the Hemophilia AIDS Collaborative Study Group.  Relationship of partially purified factor concentrates to immune tests and AIDS.  Am J Hematol 34(4):262-269, 1990.

123.Jason JM, Evatt BL, and the Hemophilia-AIDS Collaborative Study Group.  Pregnancies in human immunodeficiency virus-infected sex partners of hemophilic men.  Am J Dis Child 144(4):485-490, 1990.

124.Lauer CG, Reid TJ, Wideman CS, Evatt BL, Alving BM.  Free protein S deficiency in a family with venous thrombosis.  J Vasc Surg 12(5):541-544, 1990.

125.Hooper WC, Zaki SR, Pruckler J, Garcia J, Evatt BL.  Phorbol ester induces morphological changes and acidic fibroblast growth factor RNA expression in the RD/TE 671 cell line.  Pathobiology 58(4):198-203, 1990.

126.Zaki SR, Austin GE, Swan DC, Hooper WC, ... Evatt BL.  Studies of myeloperoxidase gene expression at the cellular level by in situ hybridization.  Leukemia 4(12):813-818, 1990.

127.Hooper WC, Zaki SR, Pruckler J, Garcia J, Evatt BL.  horbol ester induces morphological changes and acidic fibroblast growth factor RNA expression in the RD/TE 671 cell line.  Pathobiology. 58(4):198-203, 1990.

128.Black CM, McDougal JS, Evatt BL, Reimer CB.  Human markers for IgG2 and IgG4 appear to be on the same molecule in the chimpanzee.  Immunology 72(1):94-98, 1991.

129.Judd R, Zaki SR, Coffield LM, Evatt BL.  Sinonasal papillomas and human papillomavirus; human papillomavirus 11 detected in fungiform Schneiderian papillomas by in situ hybriization the polymerase chain reaction.  Human Path. 22(6):550-6, 1991.

130.Stehr-Green JK, Evatt BL, Lawrence DN.  Presenting transfusion-transmitted infections in persons with hemophilia.  In:  Transfusion Transmitted Infections.  Smith DM, Dodd RY, eds.  American Society of Clinical Pathologists Press, pp. 271-285, 1991.

131.Hooper WC, Pruckler J, Jackson D, Evatt BL.  The synergistic effect of hemin and transforming growth factor-beta on hemoglobin accumulation in HEL erythroleukmia cells.  Leukmia Research. 15(8):753-8, 1991.

132.Hooper WC, Jackson D, Pruckler J, Evatt BL.  Cellular kinetics of transforming growth factor-beta induced hemoglobin accumulation in the HEL erythroleukemia cell line.  Leukemia Research. 15(8):745-51, 1991.

133.Stahl CP, Zucker-Franklin D, Evatt BL, Winton EF.  Effects of human interleukin-6 on megakaryocyte development and thrombocytopoiesis in primates.  Blood.  78(6):1467-75, 1991.

134.Stahl CP, Winton EF, Monroe MC, Holman RC, Zelasky M, Liehl E, Myers LA, McClure H, Anderson D, Evatt BL.  Recombinant human granulocyte-macrophage colony-stimulating factor promotes megakaryocyte maturation in nonhuman primates.   Experimental Hematology. 19(8):810-6, 1991.

135.Judd R, Zaki SR, Coffield LM, Evatt BL.  Human papillomavirus type 6 detected by the polymerase chain reaction in invasive sinonasal papillary squamous cell carcinoma.  Archives of Path & Lab Med. 115(11):1150-3, 1991.

136.Ambrosino DM, Black CM, Plikaytis BD, Reimer CB, Lee MC, Evatt BL, Carlone GM.  IgG subclass values in black and white children.  Journ. Ped. 119(6):875-9, 1991.

137.Holman RC, Rhodes PH, Chorba TL, Evatt BL.  Survival of Hemophilic Males with Acquired Immunodeficiency Syndrome With and Without Risk Factors for AIDS Other Than Hemophilia.  Amer. Journ. Hematology 39:275-282, 1992.

138.Holman RC, Chorba TL, Clarke MJ, Evatt BL.  Epidemiology of AIDS in Females with Hemophilia and Other Chronic Bleeding Disorders in the United States:  Comparisons with Males with Chronic Bleeding Disorders and AIDS and with Nonhemophilic Female Blood-Transfusion Recipients with AIDS.  Amer. Journ. Hematology 41:19-23, 1992.

139.Fricke W, Augustyniak, Lawrence D, Brownstein A, Kramer A, Evatt BL.  Human immunodeficiency virus infection due to clotting factor concentrates: results of the Seroconversion Surveillance Project. Transfusion. Vol. 32, No 8--1992

140.Zaki SR, Judd R, Coffield LM, Greer P, Rolston F, Evatt BL.  Human papillomavirus infection and anl carcinoma. Retrospective analysis by in situ hybridization and the polymerase chain reaction.  Amer Journ Path. 140(6):1345-55, 1992.

141.Zucker-Franklin D, Hooper WC, Evatt BL.  Human lymphotropic retroviruses associated with mycosis fungoides: evidence that human T-cell lymphotropic virus type II (HTLV-II) as well as HTLV-I may play a rol in the disease.  Blood.  80(6):1537-45, 1992.

142.Fukuhara T, Hooper WC, Baylin SB, Benson J, Pruckler J, Olson AC, Evatt BL, Vogler WR.  Use of the polymerase chain reaction to detect hypermethylation in the calcitonin gene.  A new, sensitive approach to monitor tumor cells in acute myelogenous leukemia.  Leukemia Research. 16(10):1031-40, 1992.

143.Stahl CP, Winton EF, Monroe MC, Haff E, Holman RC, Myers L, Liehl E, Evatt BL.  Differential effects of sequential, simultaneous, and single agent interleukin-3 and granulocyte-macrophage colony-stimulating factor on megakaryocyte maturation and platelet response in primates.  Blood, 80(10):2479-85, 1992

144.Phillips DJ, Greengard JS, Fernandez JA, Ribeiro M, Evatt BL, Griffin JH, Hooper WC.  Protein S, an Antithrombotic Factor, Is Synthesized and Released by Neural Tumor Cells.  Journ. Neurochmistry. 61(1):   1993.

145.Chorba TL, Holman RC, Evatt BL.  Heterosexual and mother-to-child transmission of AIDS in the hemophilia community.  Pub. Hlth Rep 108(1):99-105, 1993 .

146.Stahl CP, Wideman CA, Spira TJ, Haff EC, Hixon GJ, Evatt BL.  Protein S Deficiency in men with Long-term Human Immunodeficiency Virus Infection. Blood. 81(7):1801-1807, 1993.

147.Stahl CS, Callaway C, Chu MC, Huang GH, Monath TP, Trent D, Evatt BL.  Replication of Colorado tick fever virus within human hematopoietic progenitor cells.  J Virol 67(4):2389-95, 1993.

148.Hilgartner MW, Donfield SM, Willoughby A, Contant CF Jr., Evatt BL, et al.  Hemophilia growth and development study.  Design, methods and entry data.  Am J Pediatr Hematol Oncol 15(2):208-18, 1993.

149.Lin JC, Lin SC, De BK, Weng-Pan C, Evatt BL.  Precision of Genotyping of Epstein-Barr Virus by Polymerase Chain Reaction Using Three Gene Loci (EBNA-2, EBNA-3C, and EBER):  Predominance of Type A Virus Associated with Hodgkin's Disease.  Blood. 81(12):3372-81, 1993.

150.Evatt B.  HIV Infection at home and in the workplace. [Review], Journal of Clinical Apheresis 8(3):161-7; discussion 181-6, 1993.

151.Phillips DJ, Greengard JS, Fernandez JA, Ribeiro M, Evatt BL, Griffin JH, Hooper WC.  Protein S, an antithrombotic factor, is synthesized and released by neural tumor cells.  J Neurochem. 61(1):344-7, 1993.

152.Black CM, McDougal JS, Holman RC, Evatt BL, Reimer CB.  Cross-reactivity of 75 monoclonal antibodies to human immunoglobulin with sera of non-human primates.  Immunology Letters. 37(2-3):207-12, 1993.

153.Griffin JH, Evatt B, Wideman C, Fernandez JA.  Anticoagulant protein C pathway defective in majority of thrombophilic patients.  Blood. 82(7):1989-93, 1993.

154.Sun Xi, Evatt BL, Griffin JH.  Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia.  Blood. 83(11):3120-3125, 1994.

155. Greengard J, Sun Xi, Xu Xiao, Fernandez J, Evatt BL, Griffin J.   Activated protein C resistance caused by ARG506Gln mutation in factor V.  Lancet 343:1361-2, 1994.

156.Cadroy Y, Hanson SR, Kelly AB, Marzec UM, Evatt BL, Kunicki TJ, Montgomery RR, Harker LA.  Relative Antithrombotic Effects of Monoclonal Antibodies Targeting Different Platelet Glyprotein-Adhesive Molecule Interations in Nonhuman Primates.  Blood, Vol. 83(11):3218-3224, 1994.

157.Phillips DJ, Evatt BE, Hooper WC.  Development of an Elisa for Quantification of Human Protein S in Cell Culture Fluids Using Commercial Polyclonal Antisera. J Immunoassay, 15(4):411-428, 1994.

158.Hooper WC, Phillips DJ, Ribeiro MJA, Benson JM, George VG, Ades EW, Evatt BL.  Tumor necrosis factor-alpha downregulates protein S secretion in human microvascular and umbilical vein endothelial cells but not in the HepG-2 hepatoma cell line.  Blood 84:483-9, 1994.

159.Hooper WC, Phillips DJ, Ribeiro M, Benson J, Evatt BL.  IL-6 Upregulates Protein S Expression in the HepG-2 Hepatoma Cells.  Thrombosis and Haemostasis, 73 (5):819-24, 1995.

160.Ribeiro MJA, Phillips DJ, Benson J, Evatt BL, Ades EW, Hooper WC. Hemostatic properties of the SV-40 transfected human microvascular endothelial cell line (HMEC-1). Thromb Research. 79:153-61, 1995.

161.Hooper WC, Phillips DJ, Evatt BL. Endothelial cell protein S synthesis is upregulated by the complex of IL-6 and soluble IL-6 receptor.  Throm Haemostasis. 77:1014, 1997

162.Hooper WC, Phillips DJ, Evatt BL.  TNF-alpha suppresses IL-6 upregulation of protein S in HepG-2 hepatoma cells.  Throm Research. 81:307, 1996.

163.Jason J, Sleeper A, Donfield SM, Murphy J, Warrier, Arkin S, Evatt BL, and the Hemophilia Growth and Development Study.  Evidence for a Shift from a Type I Lymphocyte Pattern with HIV Disease Progression.  J Acquired Immune Deficiency Syndromes and Human Retrovirology 10:471-476, 1996.

164.Evatt, BL.  AIDS and Hemophiia--Current Issues.  Thromb Haemostasis. 74:36-39, 1995.

165.Benson JM, Phillips DJ, Holloway BP, Evatt BL, Hooper WC.  Oligonucleotide ligation assay for detection of the factor V mutation (Arg506->Gln) causing protein C resistance.  Thrombosis Research. 83:1;87-96, 1996.

166.Phillips DJ, Novinger MS, Evatt BL, Hooper WC.  TNF alpha suppressed IL-1 alpha and IL-6 upregulation of C4b-binding protein in HepG-2 Hepatoma cells.  Throm Res 81(3):307-314, 1996.

167.Hooper WC, Dilley A, Ribeiro MJA, Benson J, Austin H, Silva V, Rawlins P, Wenger NK, Evatt BL.  A Racial Difference in the Prevalence of the Arg506-->Gln Mutation.  Throm Res 81(5):577-581, 1996.

168.Evatt, BL.  The CDC: Emphasis on Control and Prevention. National Hemophilia Foundation Community Alert Pamphlet, p 4-5, June 1996.

169.Evatt BL.  Blood Safety: Role of Suspected and Unexpected Infection Agents. [Report] from the Canadian Hemophilia Society Representatives, for the Dublin, Ireland June 23-28, 1996 Conference, page 8.

170.Evatt.  Disease Progression and Survival Rate Among the Hemophilia Population. Presented for the Canadian Hemophilia Society at the XI International Conference on AIDS, Vancouver 1996. [Report]from the Canadian Hemophilia Society Representatives, July 7-12, 1996, pp15-16.

171.Lobato MN, Hannan J, Simonds RJ, Riske B, Evatt BL.  Attitudes, Practices and Infection Risks of Hemophilia Treatment Center Nurses Who Teach Infection Control for the Home. Infection Control and Hospital Epidemiology. 17(11):726-731, 1996.

172.Smith PS, Teutsch SM, Shaffer PA, Rolka H, Evatt BL.  Episodic versus prophylactic infusions for hemophilia A: A cost-effectiveness analysis.  J Peds. 129(3):424-431, 1996.

173.  Evatt BL, Chorba TL, McGrady, GA, Jason JM.  AIDS in Hemophilia.  Proceedings of the 4th Technicon International Symposium pp 1-14, 1984.

174.  Hooper, WC, Dilley A, Austin H, Wenger NK, Benson J, Evatt BL, Silva V, Rawlins P.  Absence of Mutations of APC Clevage Sites Arg306 in Factor V and Arg336, Arg562 in Factor VIII in African-Americans.  Thromb Haemost 79:236, 1998.

175. Evatt BL, Hooper WC.  Infectious Complications of Blood Products. Hemophilia. ed CD Forbes, L Aledort, R Madlock.  1997, p 249.

176.  Dilley A, Austin H, Hooper WC, Lally C, Riberio MJA, Wenger NK, Silva V, Rawlins P, Evatt BL.  Relations of Three Genetic Traits to Venous Thrombosis in an African-American Population.  American Journal of Epidemiology 147(1):   1998.

177.Evatt, BL.  Prions and Haemophilia: Assessment of Risk.  Haemophilia  4: 628-633, 1998.

178.  Evatt, BL.  Public Health and International Health-Care Development for Persons with Haemophilia: Operation Improvement and Operation Access.  Haemophilia 4(Suppl.2):54-58, 1998.

179.Evatt, BL.  Control of Haemophilia: Haemophilia Care in Developing Countries.  World Health Organization, WHO/HGN/WFH/WG/98.3. 1997.

180.  JM Soucie, BH Robertson, BP Bell, KA McCaustland BL Evatt.  Hepatitis A virus associated with clotting factor concentrate in the United States.  Transfusion 38:573-579, 1998.

181.WC Hooper, DJ Phillips, MA Renshaw, BL Evatt, JM Benson.  The Up-regulation of IL-6 and IL-8 in Human Endothelial Cells by Activated Protein C.  J Immunology 161:2567-2573, 1998.

182.  Hooper WC, Evatt BL.  The role of activated protein C resistance in the pathogenesis of venous thrombosis.  Am J Med Sci. 316:120-128, 1998.

183. Austin H, Hooper WC, Dilley A, et al.  The Prevalence of Two Genetic Traits Related to Venous Thrombosis in Whites and African-Americans.  Thromb Res 86(5):409-15, 1997.

184. Dilley A, Austin, H, Hooper, WC, et al.  The Prevalence of the Prothrombin 20210 G to A Variant in African-Americans; Infants, Venus Thrombosis Patients, myocardial Infarction patients, and Controls.  J Lab Clin Med 132:452-455, 1998.

185.Soucie JM, Jackson, D, Evatt BL.  The Occurrence of Hemophilia in the United States.  AM J Hematol. 59:288-298, 1998.

186.Evatt B, Austin H, Barnhart E, Schonberer L, Sharer L, Jones R, DeArmond S. Surveillance of Creutzfeldt-Jakob disease among persons with hemophilia. Transfusion, 38:817-820, 1998.

187.Chroba TL, Holman RC, Strine TW, Clarke MJ, Evatt BL.  Changes in longevity and causes of death among persons with hemophilia A.  American J Hematology 45:112-121, 1994.

188.BL Evatt, H Austin, G Leon, A Ruiz-Saez, N DeBosch Predicting the long-term risk of HIV exposure by cryoprecipitate. Hemophilia 6(Suppl 1):128-132, 2000.

189.BH Robertson, MJ Alter, BP Bell, BL Evatt, KA McCaustland, CN Shapiro, SD Sinha, JM Soucie.  Hepatitis A Virus Sequences Detected in Clotting Factor Concentrates Associated with Disease Transmission.  Biologicals 26:95-99, 1998

190.CL Philipp, A Dilley; P Saidi, BL Evatt, H Austin, J Zawadsky, D Harwood, D Ellingsen, E Barnhart, DJ Phillips, WC Hooper.  Deletion Polymorphism in the Angiotensin-converting Enzyme Gene as a Thrombophilic Risk Factor after Hip Arthroplasty.  Thromb Haemostasis 80:869-73, 1999.

191. BL Evatt, H Austin, G Leon, A Ruiz-Saez, N DeBosch Hemophilia therapy:  assessing the cumulative risk of HIV exposure by cryoprecipiate.  Hemophilia 5,295-300, 1999.

192.CL Philipp, A Dilley; P Saidi, BL Evatt, H Austin; J Zawadsky, D Harwood, Ellingsen, E Barnhart, DJ Phillips, WC Hooper.  Deletion Polymorphism in the Angiotensin-converting Enzyme Gene as a Thrombophilic Risk Factor after Hip Arthroplasty.  Thromb Haemostasis 80:869-73, 1999.

193. LC Richardson, BL Evatt.  Risk of Hepatitis A Virus Infection in Persons with Hemophilia Receiving Plasma-Derived Products.  Transfusion Med Rev 14:64-73, 2000.

194. BL Evatt. Creutzfeldt-Jakob Disease and Hemophilia: Assessment of Risk. World Federation of Hemophilia Monograph #15. January 1999.

195. Hooper WC. Lally C. Austin H. Benson J. Dilley A. Wenger NK. Whitsett C. Rawlins P.Evatt BL. The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest. 116(4):880886, 1999.

196. Kisker CT. Mahoney EM. Arkin S. Maeder MA. Donfield SM. Evatt BL. Changes in hepatitis B serologic titers in HIV+ and HIV children with haemophilia. Haemophilia. 5(5):3549, 1999.

197. Benson JM. Ellingsen D. Renshaw MA. Resler AG. Evatt BL. Hooper WC. Multiplex analysis of mutations in four genes using fluorescence scanning technology. Thrombosis Research. 96(1):5764, 1999.

198. Austin H, Hooper WC, Lally C, Dilley A, Ellingsen D, Wideman C, Wenger NK, Rawlins P, Silva V, Evatt B. Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans. J Clin Epi 53:997-1001, 2000.

199.Dilley A, Austin H, El-Jamil M, Hooper C, Barhhart E, Evatt BL, Sullivan PS, Elligsen D, Patterson-Barnett A, Eller D, Randall H, Philipp C.  Genetic factors associated with thrombosis in pregnancy in a United States population.  Am J Obstet Gynecol 183:1271-1277, 2000.

Soucie JM, Nuss R, Evatt B, Abdelhak A, Cowan L, Hill H, Kolakoski M, Wilber N, and the Hemophilia Surveillance System Project Investigators. Mortality among males with hemophilia: relations with source of medical care. Blood 96:437-442, 2000.
201.Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Time from HIV-1 seroconversion to AIDS and widespread use of highly active antiretroviral therapy: a collaborative reanalysis.  Lancet 355:1131-1137, 2000.

202.Soucie JM, Erdman DD, Evatt BL, Anderson LJ, Torok TJ, El-Jamil M, Barnhart E, Tepper M, Burrill, HN, Pickett AM Mengeling WL. Investigation of porcine parvovirus among persons with hemophilia receiving Hyate:C porcine factor VIII concentrate. Transfusion 40: 708-711, 2000.

203.Evatt BL, Robillard L. Establishing haemophilia care in developing countries: using data to overcome the barrier of pessimism.  Haemophilia 6:131-134, 2000.

204.Hooper WC. Lally C. Austin H. Renshaw M. Dilley A. Wenger NK. Phillips DJ. Whitsett C. Rawlins P. Evatt BL.  The role of the tPA I/D and PAI1 4G/5G polymorphisms in AfricanAmerican adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res 99(3):223230, 2000.

205.Evatt BL.  Survival of haemophilia care in the developed world.  Haemophilia. 6(Suppl 2):1112, 2000.

206.Nelson MD. Wilson DA. Kisker CT. Evatt BL. Fenstermacher MJ. Lynn HS. Donfield SM. Maeder MA.  Incidence of focal white matter lesions in a population of hemophiliac children and their normal siblings.  Ped Radiology. 30(10):705709, 2000.  

207. Nuss R, Soucie JM, Evatt B et. al., Changes in the occurrences of and risk factors for hemophilia-associated intracranial hemorrhage. Am J. Hematol 2001;68:37-42.

208. Dilley A. Hooper C. Stokes M. Austin H. El-Jamil M. Evatt B. The beta-fibrinogen gene G-453-A polymorphism is a risk factor for Legg-Perthes disease. [Journal Article] Paediatric & Perinatal Epidemiology. 15(4):A8, 2001.

209. Dilley A. Hooper WC. El-Jamil M. Renshaw M. Wenger NK. Evatt BL.  Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C-->T677) and cystathione beta-synthase (CBS G-->A919, CBS T-->c833) are not associated with myocardial infarction in African Americans.  Thromb Res. 103(2):109-15, 2001.

210. J. Dilley A. Austin H. EL-Jamil M. Wolstein L. Doris J. Hooper WC. Meehan PL. Evatt B. The role of protein C, protein S, and resistance to activated protein C in Legg-Perthes disease. Pediatrics.  107(6):1329-34, 2001.

211. Hooper WC. El-Jamil M. Dilley A. Philipp C. Ellingsen D. Phillips D. Evatt BL. The relationship between the tissue plasminogen activator Alu I/D polymorphism and venous thromboembolism during pregnancy. Thromb Res. 102(1):33-7, 2001.

212. Soucie JM. Symons J 4th. Evatt B. Brettler D. Huszti H. Linden J. The Hemophilia Surveillance System Project Investigators. Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia.  Haemophilia. 7(2):198-206, 2001.

213. Hilgartner MW. Maeder MA. Mahoney EM. Donfield SM. Evatt BL. Hoots WK. Response to measles, mumps, and rubella revaccination among HIV-positive and HIV-negative children and adolescents with hemophilia. Hemophilia Growth and Development Study. Am J of Hematol. 66(2):92-8, 2001.

214. Heneine W. Switzer WM. Soucie JM. Evatt BL. Shanmugam V. Rosales GV. Matthews A. Sandstrom P. Folks TM. Evidence of porcine endogenous retroviruses in porcine factor VIII and evaluation of transmission to recipients with hemophilia. Journal of Infectious Diseases. 183(4):648-52, 2001.

215. Miller CH. Dilley A. Richardson L. Hooper WC. Evatt BL. Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women. Am J of Hematol. 67(2):125-9, 2001.

216. Dilley A. Drews C. Miller C. Lally C. Austin H. Ramaswamy D. Lurye D. Evatt B. von Willebrand disease and other inherited bleeding disorders in women with diagnosed  menorrhagia. Obstetrics & Gynecology.  97(4):630-6, 2001 Apr.

217. Soucie JM. Richardson LC. Evatt BL. Linden JV. Ewenstein BM. Stein SF. Leissinger C. Manco-Johnson M. Sexauer CL. Hemophilia Surveillance System Project Investigators. Risk factors for infection with HBV and HCV in a large cohort of hemophiliac males.  Transfusion.  41(3):338-43, 2001 Mar.

218. Chorba TL. Holman RC. Clarke MJ. Evatt BL. Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States.  Am J of Hematol. 66(4):229-40, 2001 Apr.

219.     Evatt BL. Farrugia A. Shapiro AD. Wilde JT. Haemophilia 2002: emerging risks of treatment. Haemophilia. 8(3):221-229, 2002 May.

220.Dilley A. Hooper C. Stokes M. Austin H. El-Jamil M. Evatt B. The beta-fibrinogen gene        G-453-A polymorphism is a risk factor for Legg-Perthes disease. Paediatric and Perinatal       Epidemiology. 15(4):A8, 2001.

221.Hooper WC. Dowling NF. Wenger NK. Dilley A. Ellingsen D. Evatt BL.       Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans. Am J of Hematol. 70(1):1-8, 2002.

222.Evatt BL. Observations from Global Survey 2001: an emerging database for progress. Haemophilia. 8(2):153-156, 2002.

223.Dilley A. Drews C. Lally C. Austin H. Barnhart E. Evatt B. A survey of gynecologists concerning menorrhagia: Perceptions of bleeding disorders as a possible cause. Journal of Womens Health & Gender-Based Medicine. 11(1):39-4, 2002.

224.Dilley A. Benito C. Hooper WC. Austin H. Miller C. El-Jamil M. Cottrell S. Benson J. Evatt BL. Patterson-Bamett A. Eller D. Philipp C. Mutations in the
factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss. Journal of Maternal-Fetal & Neonatal Medicine.
11(3):176-82, 2002.

225.Miller CH. Dilley AB. Drews C. Richardson L. Evatt B. Changes in von Willebrand factor and factor VIII levels during the menstrual cycle. Thrombosis & Haemostasis. 87(6):1082-3, 2002.

226.Benson JM. Ellingsen D. El-Jamil M. Jenkins M. Miller CH. Dilley A. Evatt BL. Hooper WC. Factor V Leiden and factor V R2 allele: high-throughput
analysis and association with venous thromboembolism. Thrombosis & Haemostasis. 86(5):1188-92, 2001.

Get in touch


Copyright © 2019 · All Rights Reserved · Reddy Medical Communications